[1]
“Structure Based Virtual Screening of Rivastigmine Derivatives as Cholinesterase Inhibitors”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 1, pp. 88–108, Jan. 2023, doi: 10.25004/IJPSDR.2023.150113.